Advertisement

Advertisement

BCTX Stock Latest News

BriaCell completes manufacturing for prostate cancer clinical supplies

The FlyBriaCell completes manufacturing for prostate cancer clinical supplies

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

PremiumThe Fly

BriaCell adds Penn Medicine as Phase 3 breast cancer study site

7d ago

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

PremiumThe Fly

BriaCell receives FDA clearance to initiate Bria-BRES+ trial

14d ago

BriaCell presents anti-cancer activity of Bria-OTS

PremiumThe Fly

BriaCell presents anti-cancer activity of Bria-OTS

30d ago

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

PremiumThe Fly

BriaCell presents Phase 3 quality of life, Phase 2 biomarker data at AACR

1M ago

BriaCell Therapeutics Reports Rising Losses and Funding Pressure

PremiumCompany AnnouncementsBriaCell Therapeutics Reports Rising Losses and Funding Pressure

2M ago

BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR

Company Announcements

BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR

2M ago

BriaCell to present four posters at the 2026 AACR

The Fly

BriaCell to present four posters at the 2026 AACR

2M ago

BriaCell Shareholders Approve Auditors and Reelect Board

PremiumCompany Announcements

BriaCell Shareholders Approve Auditors and Reelect Board

2M ago

BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting

PremiumCompany Announcements

BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting

3M ago

BriaCell Restructures Soluble CD80 Program via BriaPro Deal

PremiumCompany Announcements

BriaCell Restructures Soluble CD80 Program via BriaPro Deal

3M ago

BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal

PremiumCompany Announcements

BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal

3M ago

BriaPro to purchase BriaCell’s license to develop, commercialize sCD80

PremiumThe FlyBriaPro to purchase BriaCell’s license to develop, commercialize sCD80

3M ago

BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial

Company Announcements

BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial

3M ago

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

The Fly

BriaCell receives positive recommendation from DSMB for Phase 3 Bria-ABC study

3M ago

BriaCell Imaging Data Show Tumor Regression and Immune Activation in Metastatic Breast Cancer Trial

PremiumCompany Announcements

BriaCell Imaging Data Show Tumor Regression and Immune Activation in Metastatic Breast Cancer Trial

4M ago

BriaCell says patient images show regression, resolution of metastsized tumors

PremiumThe Fly

BriaCell says patient images show regression, resolution of metastsized tumors

4M ago

BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial

PremiumCompany Announcements

BriaCell Reports Prolonged Survival in Phase 2 Metastatic Breast Cancer Trial

4M ago

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

PremiumThe Fly

BriaCell extends 18-47 month survival in Phase 2 metastatic breast cancer

4M ago

BriaCell Therapeutics Completes $30 Million Public Offering

PremiumCompany AnnouncementsBriaCell Therapeutics Completes $30 Million Public Offering

4M ago

BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants

Company Announcements

BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants

4M ago

BriaCell Therapeutics trading resumes

The Fly

BriaCell Therapeutics trading resumes

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >